These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19427527)

  • 1. Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
    Luk C; Giovannoni G; Williams DR; Lees AJ; de Silva R
    J Neurosci Methods; 2009 May; 180(1):34-42. PubMed ID: 19427527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
    Yoshida M
    Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
    de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):288-302. PubMed ID: 12787326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
    Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
    J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
    Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
    Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
    Uchihara T; Hara M; Nakamura A; Hirokawa K
    Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains.
    Uchihara T; Nakamura A; Shibuya K; Yagishita S
    Brain Pathol; 2011 Mar; 21(2):180-8. PubMed ID: 20825412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
    Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
    Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Simulations Reveal Distinct Energetic and Kinetic Binding Properties of [
    Künze G; Kümpfel R; Rullmann M; Barthel H; Brendel M; Patt M; Sabri O
    ACS Chem Neurosci; 2022 Jul; 13(14):2222-2234. PubMed ID: 35762647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
    Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
    Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.
    Dan A; Takahashi M; Masuda-Suzukake M; Kametani F; Nonaka T; Kondo H; Akiyama H; Arai T; Mann DM; Saito Y; Hatsuta H; Murayama S; Hasegawa M
    Acta Neuropathol Commun; 2013 Aug; 1():54. PubMed ID: 24252707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
    Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.
    Kovacs GG; Kwong LK; Grossman M; Irwin DJ; Lee EB; Robinson JL; Suh E; Van Deerlin VM; Lee VM; Trojanowski JQ
    Brain Pathol; 2018 Mar; 28(2):274-283. PubMed ID: 28019685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
    Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.